Drug Profile
CP 465022
Alternative Names: CP 46502227Latest Information Update: 15 Mar 2000
Price :
$50
*
At a glance
- Originator Pfizer
- Class Antiepileptic drugs; Neuroprotectants
- Mechanism of Action AMPA receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Seizures
Most Recent Events
- 15 Mar 2000 No-Development-Reported for Seizures in USA (Unknown route)
- 14 Dec 1998 New profile
- 14 Dec 1998 Preclinical development for Seizures in USA (Unknown route)